Matt Hewitt
Stock Analyst at Craig-Hallum
(4.40)
# 1,231
Out of 5,040 analysts
727
Total ratings
46.8%
Success rate
8%
Average return
Main Sectors:
Stocks Rated by Matt Hewitt
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QTI QT Imaging Holdings | Initiated Coverage: Buy | $8 | $2.56 | +212.50% | 1 | Oct 5, 2026 | |
| BHST BioHarvest Sciences | Reiterated: Buy | n/a | $1.50 | - | 20 | Sep 29, 2026 | |
| LFCR Lifecore Biomedical | Downgraded: Hold | $6.28 | $6.43 | -2.33% | 40 | Sep 29, 2026 | |
| OABI OmniAb | Reiterated: Buy | n/a | $4.66 | - | 32 | Sep 29, 2026 | |
| RGEN Repligen | Reiterated: Buy | n/a | $163.84 | - | 58 | Sep 25, 2026 | |
| INFU InfuSystem Holdings | Reiterated: Buy | n/a | $13.41 | - | 21 | Sep 24, 2026 | |
| LGND Ligand Pharmaceuticals | Rated: Buy | n/a | $295.00 | - | 72 | Sep 24, 2026 | |
| PARK Park Dental Partners | Reiterated: Buy | n/a | $20.60 | - | 9 | Sep 24, 2026 | |
| CDXS Codexis | Reiterated: Buy | n/a | $1.36 | - | 53 | Sep 22, 2026 | |
| TKNO Alpha Teknova | Reiterated: Buy | n/a | $8.44 | - | 22 | Sep 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $7.21 | - | 32 | Sep 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $34.83 | - | 49 | Sep 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $0.4444 | +800.09% | 14 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $16.90 | +18.34% | 9 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $8.64 | - | 18 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $26.39 | - | 52 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.02 | - | 36 | Jul 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $4.64 | - | 2 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $2.36 | +154.24% | 55 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $32.47 | +23.19% | 30 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.2869 | - | 1 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $81.58 | - | 1 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $4.98 | +140.96% | 20 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $2.54 | - | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $4.58 | - | 12 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $25.29 | n/a | 1 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $16.02 | n/a | 13 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $42.78 | n/a | 1 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $0.7088 | n/a | 2 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.09 | n/a | 15 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $6 | $2.97 | n/a | 1 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $8.22 | n/a | 1 | Sep 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $5.54 | n/a | 22 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $16 → $17 | $11.23 | n/a | 2 | Oct 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $100 | $0.0002 | n/a | 1 | Jan 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $215 → $154 | $72.47 | n/a | 3 | Oct 31, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 | $4.62 | n/a | 4 | Feb 27, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $50 | $119.47 | n/a | 1 | Nov 8, 2017 |
QT Imaging Holdings
Oct 5, 2026
Initiated Coverage: Buy
Price Target: $8
Current: $2.56
Upside: +212.50%
BioHarvest Sciences
Sep 29, 2026
Reiterated: Buy
Price Target: n/a
Current: $1.50
Upside: -
Lifecore Biomedical
Sep 29, 2026
Downgraded: Hold
Price Target: $6.28
Current: $6.43
Upside: -2.33%
OmniAb
Sep 29, 2026
Reiterated: Buy
Price Target: n/a
Current: $4.66
Upside: -
Repligen
Sep 25, 2026
Reiterated: Buy
Price Target: n/a
Current: $163.84
Upside: -
InfuSystem Holdings
Sep 24, 2026
Reiterated: Buy
Price Target: n/a
Current: $13.41
Upside: -
Ligand Pharmaceuticals
Sep 24, 2026
Rated: Buy
Price Target: n/a
Current: $295.00
Upside: -
Park Dental Partners
Sep 24, 2026
Reiterated: Buy
Price Target: n/a
Current: $20.60
Upside: -
Codexis
Sep 22, 2026
Reiterated: Buy
Price Target: n/a
Current: $1.36
Upside: -
Alpha Teknova
Sep 17, 2026
Reiterated: Buy
Price Target: n/a
Current: $8.44
Upside: -
Sep 15, 2026
Reiterated: Buy
Price Target: n/a
Current: $7.21
Upside: -
Sep 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $34.83
Upside: -
Aug 13, 2026
Reiterated: Buy
Price Target: $4
Current: $0.4444
Upside: +800.09%
Aug 7, 2026
Reiterated: Buy
Price Target: $20
Current: $16.90
Upside: +18.34%
Aug 4, 2026
Reiterated: Hold
Price Target: n/a
Current: $8.64
Upside: -
Jul 8, 2026
Reiterated: Buy
Price Target: n/a
Current: $26.39
Upside: -
Jul 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $1.02
Upside: -
Jun 2, 2026
Reiterated: Hold
Price Target: n/a
Current: $4.64
Upside: -
May 8, 2026
Reiterated: Buy
Price Target: $6
Current: $2.36
Upside: +154.24%
May 6, 2026
Reiterated: Buy
Price Target: $40
Current: $32.47
Upside: +23.19%
Mar 25, 2026
Reiterated: Buy
Price Target: n/a
Current: $0.2869
Upside: -
Feb 23, 2026
Reiterated: Buy
Price Target: n/a
Current: $81.58
Upside: -
Dec 16, 2025
Reiterated: Buy
Price Target: $12
Current: $4.98
Upside: +140.96%
Dec 9, 2025
Reiterated: Buy
Price Target: n/a
Current: $2.54
Upside: -
Oct 10, 2025
Reiterated: Buy
Price Target: n/a
Current: $4.58
Upside: -
Jun 17, 2025
Rated: Hold
Price Target: n/a
Current: $25.29
Upside: n/a
Apr 25, 2025
Reiterated: Buy
Price Target: n/a
Current: $16.02
Upside: n/a
Mar 18, 2025
Reiterated: Buy
Price Target: n/a
Current: $42.78
Upside: n/a
Dec 18, 2024
Rated: Buy
Price Target: n/a
Current: $0.7088
Upside: n/a
Aug 7, 2024
Reiterated: Buy
Price Target: n/a
Current: $1.09
Upside: n/a
Feb 9, 2024
Rated: Buy
Price Target: $6
Current: $2.97
Upside: n/a
Sep 21, 2023
Reiterated: Buy
Price Target: n/a
Current: $8.22
Upside: n/a
Feb 23, 2023
Rated: Hold
Price Target: n/a
Current: $5.54
Upside: n/a
Oct 4, 2019
Reiterated: Hold
Price Target: $16 → $17
Current: $11.23
Upside: n/a
Jan 18, 2019
Reiterated: Hold
Price Target: $100
Current: $0.0002
Upside: n/a
Oct 31, 2018
Downgraded: Hold
Price Target: $215 → $154
Current: $72.47
Upside: n/a
Feb 27, 2018
Reiterated: Buy
Price Target: $19
Current: $4.62
Upside: n/a
Nov 8, 2017
Reiterated: Hold
Price Target: $50
Current: $119.47
Upside: n/a